New Medicare-negotiated prices for 15 widely used medications take effect in 2027, impacting more than 5 million ...

Glenmark Pharmaceuticals added 1.75% after the company announced launch of Nebzmart GFB Smartules and Glenmark Airz FB Smartules, the world's first nebulized, fixed-dose triple therapy for Chronic ...

The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world's first nebulised, fixed-dose ...

Glenmark Pharma launches Nebzmart GFB & Airz FB Smartules, a fixed-dose triple therapy for COPD. Improves lung function & ...

Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment ...

Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health ...

The arrival of cold weather can exacerbate the condition, causing difficulty in breathing due to airway irritation, pollution ...

To kick off National Influenza Vaccination Week (December 1 - 6), the American Heart Association®, American Lung Association®, American Diabetes Association® (ADA) and National Foundation for ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...